4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-044054
Chief Executive Officer sold 3,000 shares at $51.18 ($153,540)
- Chief Executive Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Chief Executive Officer | 2017-07-03 | Option exercise | +3,000 | $0.30 | $908 | 3,000 | D |
| Schenkein David P Chief Executive Officer | 2017-07-03 | Sale | −3,000 | $51.18 | $153,540 | 0 | D |
| Derivatives | |||||||
| Schenkein David P Chief Executive Officer | 2017-07-03 | Option exercise · Stock option (right to buy) | −3,000 | 186,656 | D | ||
| Open-market sales · 3,000 sh · avg $51.18 · $153,540 | |||||||
Loading xslF345X03/doc4.xml…